Bronchial Diseases

• Novartis Investigative Site — Berlin, Germany
• Novartis Investigative Site — Munich, Germany
• Novartis Investigative Site — Wiesbaden, Germany
• Novartis Investigative Site — Ahmedabad, India

• GSK Investigational Site — Shenzhen, Guangdong, China
• GSK Investigational Site — Zhanjiang, Guangdong, China
• GSK Investigational Site — Nanning, Guangxi, China
• GSK Investigational Site — Haikou, Hainan, China

• Research Site — Gliwice, Poland
• Research Site — Karpacz, Poland
• Research Site — Lodz, Poland

• Gachon University Gil Medical Center — Incheon, South Korea

• Orion Pharma pharmacology Unit — Espoo, Finland

Not specified

• Forest Investigative Site 909 — Phoenix, Arizona, United States
• Forest Investigative Site 2066 — Encinitas, California, United States
• Forest Investigative Site 1624 — Los Angeles, California, United States
• Forest Investigative Site 1995 — Mission Viejo, California, United States

• Forest Investigative Site 0909 — Glendale, Arizona, United States
• Forest Investigative Site 2050 — Pheonix, Arizona, United States
• Forest Investigative Site 2029 — Rancho Mirage, California, United States
• Forest Investigative Site 1084 — Stockton, California, United States

• MHAT St. Ivan Rilski-2003 Ltd., Department of Internal Medicine — Dupnitsa, Bulgaria
• SHATPPD - Pazardzhik EOOD, Department of phthisiatrics pneumonia and pulmonary functional diagnostics — Pazardzhik, Bulgaria
• Medical Center - Razgrad OOD, Office of Pneumonology and Phthisiatry — Razgrad, Bulgaria
• Medical Center Smolyan OOD, Office of Clinical Allergology — Smolyan, Bulgaria

• VA Healthcare System — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States